1
TABLE 2. H NMR Spectra of Compounds 4b-d, 5b-d, 7b-d and their
Tautomeric Forms 4'b-d, 5'd
Compound
1Н NMR spectrum, δ, ppm, J (Hz)
4b*
4'b
4.79 (2Н, s, СН2СO); 8.17-8.36 (4Н, m, p-С6Н4)*2
6.15 (1Н, s, СНСO); 7.18-7.74 (4Н, m, o-С6Н4); 8.10-8.32 (4Н, m, p-С6Н4);
12.43 (1Н, s, NH)
4c*
4'c
4.70 (2Н, s, СН2СO); 7.50-8.03 (4Н, m, p-С6Н4)*2
6.05 (1Н, s, СНСO); 7.63-8.12 (4Н, m, p-С6Н4); 7.15-7.59 (4Н, m, o-С6Н4);
12.29 (1Н, s, NH)
4d*
4'd
5b
3.82 (3Н, s, OСН3); 4.61 (2Н, s, СН2СO); 7.07-8.09 (4Н, m, p-С6Н4);
7.13-7.53 (4Н, m, o-С6Н4); 12.36 (1Н, s, NH)
3.86 (3Н, s, OСН3); 6.02 (1Н, s, СНСO); 7.00-7.84 (4Н, m, p-С6Н4);
12.21 (1Н, s, NH)*2
4.29 (2Н, s, СН2); 7.12-7.49 (4Н, m, o-С6Н4); 7.69 (2Н, s, NH2);
7.96-8.19 (4Н, m, p-С6Н4); 12.37 (1Н, s, NH)
4.22 (2Н, s, СН2); 7.12-7.52 (4Н, m, o-С6Н4); 7.20 (2Н, br. s, NH2);
5c
7.36-7.79 (4Н, m, p-С6Н4); 12.37 (1Н, br. s, NH)
5d*3
3.75 (3Н, s, СН3); 4.20 (2Н, s, СН2); 6.87-7.23 (4Н, m, p-С6Н4);
6.96 (2Н, br. s, NH2); 7.12-7.50 (4Н, m, o-С6Н4); 12.38 (1Н, br. s, NH)
4.72 (2H, s, CH); 6.92-7.94 (4Н, m, p-С6Н4)*2
5'd
7b
7.32-7.44 (2Н, m, 5-, 6-H); 7.52 (1H, s, 4'-H); 7.79 (1H, d, J = 8, 4-H);
8.11 (1H, d, J = 8, 7-H); 8.12-8.43 (4H, m, p-С6Н4); 8.76 (1H, s, 2-H);
13.93 (1H, s, NH)
7.30 (1H, s, 4'-H); 7.31-7.44 (2Н, m, 5-, 6-Н); 7.61-7.91 (4Н, m, p-С6Н4);
7.79 (1H, d, J = 8, 4-Н); 8.11 (1Н, d, J = 8, 7-Н); 8.75 (1H, s, 2-H);
13.63 (1H, s, NH)
3.83 (3H, s, CH3); 7.09-7.82 (4H, m, p-С6Н4); 7.15 (1Н, s, 4'-H);
7.31-7.43 (2Н, m, 5-, 6-Н); 7.79 (1Н, d, J = 7, 4-Н); 8.12 (1Н, d, J = 8, 7-Н);
8.75 (1H, s, 2-H); 13.41 (1H, s, NH)
7c
7d
_______
* Tautomeric ratio of 4 and 4' 4:96 (b), 12:88 (c), 52:48 (d).
*2 Remaining signals obscured by the signals of the tautomer.
*3 Tautomeric ratio of 5d and 5'd 80:20.
Secondly, the transfer from the hydrazone form to the enhydrazine leads to an increase in the nucleophilicity of
the amino group in compounds with electron-acceptor substituents and, on the other hand, to its lowering with
the methoxy-substituted compound. Thirdly, in the hydrazone form the effect of the substituent on the
electrophilic center is insignificant but shows up in the nucleophile (an electron acceptor lowering its reactivity
and a methoxy group increasing it). Fourthly, and contrariwise, in the enhydrazine form the effect of the
substituent on the nucleophilic center is insignificant but shows up in the electrophile (an electron acceptor
increases its activity and a methoxy group lowers it). Correlation of such complex electronic effects with
experimental data obtained is possible if one infers that the tendency of the hydrazones discussed towards
recyclization is determined by the reactivity of the electrophilic center. It follows from this that: 1) the
recyclization of compounds with electron acceptor substituents is highly favored in the enhydrazine form; 2) for
recyclization of compound 5a in the enhydrazine form a long reaction time is necessary; and 3) the tendency of
the methoxy-substituted compound 5d to recyclize is distinctly weak, particularly in the enhydrazine form.
It should also be born in mind that the values of the aromatic indices for the benzimidazole and pyrazole
rings are extremely similar (0.050 and 0.055 respectively [8]). Hence the thermodynamic factors do not favor
reconstruction of the benzimidazole ring to a pyrazole. This recyclization probably has an equilibrium character;
separation of its products without the use of DMF could not be achieved.
DMF reacts with the recyclization products 6a-d at the amino group of the o-phenylenediamine
fragment. Its reactivity is typical of an aniline and is virtually independent of the effect of the substituent in the
pyrazole ring due to the absence of system conjugation. Of course, DMF can react at both the amino group of
1099